Alopecia Market Size, Share & Trends Analysis Report By Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), By Treatment, By Gender, By Sales Channel, By End-use, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: 978-1-68038-856-5
- Number of Pages: 120
- Format: Electronic (PDF)
- Historical Range: 2018 - 2022
- Industry: Healthcare
Market Segmentation
- Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Gender Outlook (Revenue in USD Million; 2018 - 2030)
- Male
- Female
- Sales Channel Outlook (Revenue in USD Million; 2018 - 2030)
- Prescriptions
- OTC
- End Use Outlook (Revenue in USD Million; 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- North America Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- North America Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- North America Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- North America End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- U.S.
- U.S. Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- U.S. Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- U.S. Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- U.S. Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- U.S. End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- U.S. Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Canada
- Canada Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Canada Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Canada Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Canada Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Canada End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Canada Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- North America Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Europe
- Europe Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Europe Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Europe Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Europe Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Europe End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Germany
- Germany Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Germany Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Germany Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Germany Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Germany End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Germany Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- UK
- UK Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- UK Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- UK Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- UK Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- UK End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- UK Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- France
- France Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- France Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- France Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- France Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- France End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- France Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Italy
- Italy Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Italy Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Italy Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Italy Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Italy End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Italy Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Spain
- Spain Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Spain Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Spain Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Spain Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Spain End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Spain Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Denmark
- Denmark Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Denmark Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Denmark Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Denmark Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Denmark End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Denmark Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Sweden
- Sweden Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Sweden Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Sweden Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Sweden Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Sweden End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Sweden Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Norway
- Norway Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Norway Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Norway Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Norway Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Norway End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Norway Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Europe Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Asia Pacific
- Asia Pacific Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Asia Pacific Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Asia Pacific Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Asia Pacific Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Asia Pacific End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- China
- China Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- China Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- China Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- China Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- China End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- China Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Japan
- Japan Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Japan Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Japan Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Japan Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Japan End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Japan Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- India
- India Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- India Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- India Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- India Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- India End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- India Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Thailand
- Thailand Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Thailand Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Thailand Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Thailand Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Thailand End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Thailand Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- South Korea
- South Korea Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- South Korea Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- South Korea Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- South Korea Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- South Korea End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- South Korea Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Australia
- Australia Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Australia Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Australia Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Australia Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Australia End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Australia Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Asia Pacific Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Latin America
- Latin America Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Latin America Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Latin America Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Latin America Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Latin America End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Brazil
- Brazil Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Brazil Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Brazil Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Brazil Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Brazil End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Brazil Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Mexico
- Mexico Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Mexico Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Mexico Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Mexico Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Mexico End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Mexico Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Argentina
- Argentina Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Argentina Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Argentina Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Argentina Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Argentina End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Argentina Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Latin America Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Middle East and Africa
- Middle East and Africa Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Middle East and Africa Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Middle East and Africa Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Middle East and Africa Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Middle Wast and Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- South Africa
- South Africa Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- South Africa Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- South Africa Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- South Africa Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- South Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- South Africa Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Saudi Arabia
- Saudi Arabia Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Saudi Arabia Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Saudi Arabia Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Saudi Arabia Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Saudi Arabia End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Saudi Arabia Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- UAE
- UAE Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- UAE Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- UAE Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- UAE Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- UAE End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- UAE Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Kuwait
- Kuwait Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Alopecia Areata
- Male
- Female
- Cicatricial Alopecia
- Male
- Female
- Traction Alopecia
- Male
- Female
- Alopecia Totalis
- Male
- Female
- Alopecia Universalis
- Male
- Female
- Androgenetic Alopecia
- Male
- Female
- Others
- Male
- Female
- Alopecia Areata
- Kuwait Treatment Outlook (Revenue in USD Million, 2018 - 2030)
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- OTC
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- Topical
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- Pharmaceuticals
- Kuwait Gender Outlook (Revenue in USD Million, 2018 - 2030)
- Male
- Female
- Kuwait Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
- Prescriptions
- OTC
- Kuwait End Use Outlook (Revenue in USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
- Kuwait Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- Middle East and Africa Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
- North America
Alopecia Market Dynamics
Driver: Increasing Prevalence of Alopecia
The growing prevalence of alopecia in most countries owing to changing lifestyles, such as huge consumption of junk food, alcohol, and tobacco. Rise in stress level coupled with increasing geriatric population. These factors are responsible for the increase in alopecia cases. According to data published by the American Hair Loss Association, it was stated that over 95% of hair loss in men is caused due to androgenetic alopecia. The occurrence of hair loss in men increases proportionately with age. Based on the report published by the International Society of Hair Restoration Surgery, it was estimated that nearly 40% of men encounter some degree of hair loss by 35 years of age, 65% at 60 years, 70% at 80 years, and 80% at the age of 85.
Driver: Growing Healthcare Expenditure to Boost Market Growth
The number of healthcare expenditures is growing in several regions such as North American, Asia Pacific, Latin American, and Europe. The key factors responsible to drive healthcare expenditure include rapidly increasing geriatric population, increasing consumer disposable income, and growing emphasis on aesthetic appearance is further responsible for accelerating healthcare expenditure, thereby improving the market. In addition, rapid economic growth in developing countries along with several initiatives by organizations such as American Hair Loss Association and National Alopecia Areata Foundation spreading awareness of alopecia treatment which drive the market growth over the forecast period.
Restraint: Increasing Adoption of Alternatives to Hamper Market Growth
Increased adoption of substitutes such as - Ayurvedic, Chinese, and herbal medications is anticipated to hamper market growth in the coming years. Furthermore, growing advanced technology in the healthcare industry has posed a threat to growth of the alopecia market.
What Does This Report Include?
This section will provide insights into the contents included in this alopecia market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Alopecia market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Alopecia market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
